ACE2 and COVID-19: Recently, our group demonstrated the involvement of the Leukotriene B4 (LTB4) pathway in severe cases of COVID-19 in individuals with diabetes, and reported increased expression of ACE2 and TMPRSS2 in peripheral blood mononuclear cells (3).